Breaking News Instant updates and real-time market news.

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42

Zoetis CEO says: 'Diagnostics are more important in animals than humans'

In an interview on CNBC's Mad Money, Zoetis CEO Juan Ramon Alaix said: "Diagnostics are more important in animals than humans... We are doing very well in China... China is the third largest country for us... Apoquel is treating allergic reactions in dogs and it's doing very well."

ZTS Zoetis
$95.38

2.16 (2.32%)

02/12/19
CLVD
02/12/19
NO CHANGE
CLVD
Buy
Zoetis channel feedback positive on 2019, says Cleveland Research
Cleveland Research analyst Rob Eich said the firm's feedback from the channel indicates quarterly trends were mixed for Zoetis but that 2019 looks positive due to strong share gains and continued new product strength. The analyst, who added that his work points to Zoetis having recently won a contract with a U.K. hospital chain that has over 500 vets, keeps a Buy rating on Zoetis shares.
01/23/19
UBSW
01/23/19
INITIATION
Target $86
UBSW
Neutral
Zoetis initiated with a Neutral at UBS
UBS analyst Navin Jacob started Zoetis with a Neutral rating and $86 price target. The company's strong Fundamentals are offset by the current valuation, the analyst says.
12/19/18
BMOC
12/19/18
NO CHANGE
Target $32
BMOC
Market Perform
Elanco price target lowered to $32 from $37 at BMO Capital
BMO Capital analyst Alex Arfaei lowered his price target on Elanco (ELAN) to $32 and kept his Market Perform rating, saying its FY19 guidance was "modestly below" his expectations and that he doubts that the management is being conservative. The analyst also cites "significant uncertainties" in 2020 related to competitor's products and the company's R&D productivity, also lowering his FY19 EPS view to $1.13 from $1.22. Arfaei believes that the market valuation on Elanco similar to Zoetis (ZTS) is "premature" based on the "important differences in revenue growth potential, product mix, and execution track record" of the two companies.
11/12/18
BMOC
11/12/18
NO CHANGE
Target $93
BMOC
Market Perform
Zoetis price target raised to $93 from $86 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Zoetis to $93 after its Q3 earnings beat and raised FY18 guidance. The analyst acknowledges that the company's "commercial and R&D execution have been excellent", leading to its premium valuation. Arfaei keeps his Market Perform on Zoetis however, noting that in spite of its performance amid the reasonably high expectations, the company's insufficient pipeline visibility and premium valuation warrant a neutral stance.

TODAY'S FREE FLY STORIES

ZUO

Zuora

$24.35

0.63 (2.66%)

16:13
03/21/19
03/21
16:13
03/21/19
16:13
Earnings
Zuora sees Q1 EPS (14c) to (13c), consensus (13c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 23

    Apr

CAL

Caleres

$25.75

-0.08 (-0.31%)

16:13
03/21/19
03/21
16:13
03/21/19
16:13
Earnings
Caleres sees FY19 adjusted EPS $2.45-$2.55, consensus $2.49 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

OPNT

Opiant Pharmaceuticals

$14.00

0.5 (3.70%)

16:12
03/21/19
03/21
16:12
03/21/19
16:12
Earnings
Opiant sees cash balance of $17M-$20M at end of FY19 »

At December 31, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

AVDR

Avedro

$12.15

-0.99 (-7.53%)

16:12
03/21/19
03/21
16:12
03/21/19
16:12
Earnings
Breaking Earnings news story on Avedro »

Avedro sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CAL

Caleres

$25.74

-0.09 (-0.35%)

16:12
03/21/19
03/21
16:12
03/21/19
16:12
Earnings
Caleres reports Q4 adjusted EPS 38c, consensus 45c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

ZUO

Zuora

$24.33

0.61 (2.57%)

16:11
03/21/19
03/21
16:11
03/21/19
16:11
Earnings
Zuora reports Q4 adjusted EPS (11c), consensus (11c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 23

    Apr

OPNT

Opiant Pharmaceuticals

$14.00

0.5 (3.70%)

16:11
03/21/19
03/21
16:11
03/21/19
16:11
Earnings
Opiant reports Q4 EPS (37c), consensus (13c) »

Reports Q4 revenue $4.8M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

AVDR

Avedro

$12.15

-0.99 (-7.53%)

16:11
03/21/19
03/21
16:11
03/21/19
16:11
Earnings
Avedro reports Q4 revenue $8.21M, consensus $7.97 »

Net loss was $6.4M in Q4,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

PKI

PerkinElmer

$97.49

2.46 (2.59%)

16:11
03/21/19
03/21
16:11
03/21/19
16:11
Syndicate
Breaking Syndicate news story on PerkinElmer »

PerkinElmer files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

AGN

Allergan

$153.41

-0.26 (-0.17%)

, SIEN

Sientra

$9.78

0.025 (0.26%)

16:10
03/21/19
03/21
16:10
03/21/19
16:10
Hot Stocks
FDA posts briefing documents for advisory panel on breast implants »

The Food and Drug…

AGN

Allergan

$153.41

-0.26 (-0.17%)

SIEN

Sientra

$9.78

0.025 (0.26%)

ESTA

Establishment Labs

$27.05

-0.85 (-3.05%)

JNJ

Johnson & Johnson

$138.15

0.92 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 16

    Apr

  • 25

    Apr

  • 18

    May

  • 28

    May

GME

GameStop

$10.52

0.04 (0.38%)

16:08
03/21/19
03/21
16:08
03/21/19
16:08
Hot Stocks
GameStop appoints George Sherman as CEO »

GameStop Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 16

    Apr

CNAT

Conatus

$2.88

-0.01 (-0.35%)

16:08
03/21/19
03/21
16:08
03/21/19
16:08
Hot Stocks
Conatus announces Phase 2b ENCORE-NF trial results »

Conatus announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNNA

Sienna Biopharmaceuticals

$2.82

0.05 (1.81%)

16:07
03/21/19
03/21
16:07
03/21/19
16:07
Hot Stocks
Sienna Biopharmaceuticals promotes Alexander Azoy to CFO »

Sienna Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELF

e.l.f. Beauty

$9.85

-0.01 (-0.10%)

16:06
03/21/19
03/21
16:06
03/21/19
16:06
Hot Stocks
e.l.f. Beauty names Mandy Fields new CFO »

e.l.f. Beauty announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$26.35

0.55 (2.13%)

16:05
03/21/19
03/21
16:05
03/21/19
16:05
Hot Stocks
PulteGroup names John Chadwick COO »

PulteGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VREX

Varex Imaging

$34.18

0.22 (0.65%)

16:05
03/21/19
03/21
16:05
03/21/19
16:05
Hot Stocks
Varex Imaging acquiring Swedish linear array digital detector maker »

Varex Imaging has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

GRTS

Gritstone Oncology

$11.25

-0.45 (-3.85%)

16:04
03/21/19
03/21
16:04
03/21/19
16:04
Hot Stocks
Gritstone Oncology announces first patient dosed with GRANITE-001 »

Gritstone Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$22.07

-0.07 (-0.32%)

, BHGE

Baker Hughes

$28.51

0.25 (0.88%)

16:04
03/21/19
03/21
16:04
03/21/19
16:04
Hot Stocks
Yext names George Murphy as SVP, Global Strategic Alliances »

Yext (YEXT) has appointed…

YEXT

Yext

$22.07

-0.07 (-0.32%)

BHGE

Baker Hughes

$28.51

0.25 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

  • 19

    Mar

OXFD

Oxford Immunotec

$18.00

0.04 (0.22%)

, GE

General Electric

$10.29

0.08 (0.78%)

16:03
03/21/19
03/21
16:03
03/21/19
16:03
Hot Stocks
Oxford Immunotec appoints Matthew McLaughlin CFO »

Oxford Immunotec Global…

OXFD

Oxford Immunotec

$18.00

0.04 (0.22%)

GE

General Electric

$10.29

0.08 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 08

    May

ACGL

Arch Capital

$32.35

0.36 (1.13%)

16:02
03/21/19
03/21
16:02
03/21/19
16:02
Hot Stocks
Arch Capital names John Pasquesi chairman of the board »

Arch Capital Group Ltd.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOK

Nokia

$6.32

0.03 (0.48%)

16:01
03/21/19
03/21
16:01
03/21/19
16:01
Hot Stocks
Nokia reports internal investigation into compliance at Alcatel Lucent »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

BIIB

Biogen

$225.22

-95.25 (-29.72%)

15:59
03/21/19
03/21
15:59
03/21/19
15:59
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

CNC

Centene

$58.93

0.24 (0.41%)

15:55
03/21/19
03/21
15:55
03/21/19
15:55
Options
Centene put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 09

    May

  • 28

    May

NOK

Nokia

$6.30

0.005 (0.08%)

15:52
03/21/19
03/21
15:52
03/21/19
15:52
Periodicals
Finland to investigate Nokia-branded phones over data breach report,Reuters says »

Finland's data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

CAL

Caleres

$25.72

-0.11 (-0.43%)

15:34
03/21/19
03/21
15:34
03/21/19
15:34
Options
Caleres options imply 11.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.